Company · CIK 0001133869 · SIC 2834 — Pharmaceutical Preparations · Nasdaq

CAPRICOR THERAPEUTICS, INC. · CAPR

Insider activity reported against this company. All insider holders · On EDGAR ↗

Period1M 3M 6M 1Y 2Y All datashares as filed — not split-adjusted

Open-market buys & salesbuys $0 · 0sales $1.5M · 4net −$1.5M

Reported at this company — common stock

Trade	Reported (ET)	Insider	Shares	Avg price	Total	Owned after	Δ stake
Jun 25, 2026 SForm 4 →	Jun 29, 9:30 pm EDT	Karen KrasneyEVP, GENERAL COUNSEL	24,100	$30.38	$732,158	30,547	−44.1%
Jun 25, 2026 MForm 4 →	Jun 29, 9:30 pm EDT	Karen KrasneyEVP, GENERAL COUNSEL	24,100	$3.18	$76,638	54,647	—
Jun 25, 2026 SForm 4 →	Jun 29, 9:30 pm EDT	Anthony BergmannCHIEF FINANCIAL OFFICER	24,100	$30.38	$732,158	11,223	−68.2%
Jun 25, 2026 MForm 4 →	Jun 29, 9:30 pm EDT	Anthony BergmannCHIEF FINANCIAL OFFICER	24,100	$3.18	$76,638	35,323	—
Jun 22, 2026 SForm 4 →	Jun 24, 8:00 pm EDT	Karen KrasneyEVP, GENERAL COUNSEL	900	$30.00	$27,000	30,547	−2.86%
Jun 22, 2026 MForm 4 →	Jun 24, 8:00 pm EDT	Karen KrasneyEVP, GENERAL COUNSEL	900	$3.18	$2,862	30,947	—
Jun 22, 2026 SForm 4 →	Jun 24, 8:00 pm EDT	Anthony BergmannCHIEF FINANCIAL OFFICER	900	$30.00	$27,000	11,223	−7.42%
Jun 22, 2026 MForm 4 →	Jun 24, 8:00 pm EDT	Anthony BergmannCHIEF FINANCIAL OFFICER	900	$3.18	$2,862	11,623	—

Trade	Reported (ET)	Insider	Shares	Avg price	Total	Owned after	Δ stake
Jun 25, 2026 MForm 4 →	Jun 29, 9:30 pm EDT	Karen KrasneyEVP, GENERAL COUNSEL	24,100	—	—	31,261	—
Jun 25, 2026 MForm 4 →	Jun 29, 9:30 pm EDT	Anthony BergmannCHIEF FINANCIAL OFFICER	24,100	—	—	91,980	—
Jun 22, 2026 MForm 4 →	Jun 24, 8:00 pm EDT	Karen KrasneyEVP, GENERAL COUNSEL	900	—	—	55,361	—
Jun 22, 2026 MForm 4 →	Jun 24, 8:00 pm EDT	Anthony BergmannCHIEF FINANCIAL OFFICER	900	—	—	116,080	—